MD Education

Thor Halfdanarson: It is not all about tumor shrinkage after PRRT

Thor Halfdanarson, Medical Oncologist at Mayo Clinic, shared a post on X:

“It is not all about tumor shrinkage after PRRT.
In this NETTER-1 analysis, PFS and OS were not different in patients where tumor shrinkage was seen. Not a new observation but a topic I discuss every week with patients. Benefits can be seen without high ORR…”

“Relationship Between Best Tumor Shrinkage and Progression-Free Survival and Overall Survival in Patients With Progressive Midgut Neuroendocrine Tumors Treated With [177Lu]Lu-DOTA-TATE: Ad Hoc Analysis of the Phase III NETTER-1 Trial.”

Authors: Marianne Pavel, Martyn E. Caplin, Philippe Ruszniewski, Marianna Hertelendi, Eric P. Krenning, Jonathan R. Strosberg

Thor Halfdanarson: It is not all about tumor shrinkage after PRRT

cancer Eric P. Krenning Jonathan R. Strosberg Marianna Hertelendi Marianne Pavel Martyn E. Caplin OncoDaily Oncology Philippe Ruszniewski Thor Halfdanarson